Table 1.
Study | Country | Study design | Inclusion/exclusion criteria | Data collection | Study period (year) | Medicine category | Sample size | Female (%) | Age (years) | Number of medications | Prevalence of polypharmacy (%) (cut-off) |
---|---|---|---|---|---|---|---|---|---|---|---|
Acute care setting | |||||||||||
Hudhra54 |
Albania Non-EU, UMIC |
Cross-sectional | 60 + years & discharged from internal medicine and cardiology department | Medical charts | 2013 | Rx | 319 | 43.6 | M 69.7 SD 6.1 Ra 60–89 | M 7.8 SD 2.2 | 73.0 (7 +) |
Matanovic56 |
Croatia EU, HIC |
Cross-sectional | 65 + years & emergency admission to the internal medicine department | Medical charts & interview (patient, GP)a | 2009–2010 | Rx, OTCb | 454 | 57.7 | M 74.8 SD 4.2 Ra 65–94a | M 5.3 SD 2.9 | 57.5 (5 +) |
Mucalo57 |
Croatia EU, HIC |
Cross-sectional | 65 + years & 1 + medication & hospitalised at the internal medicine department & patient/proxy capable of giving consent and communicating well | Medical charts & interview (patient/caregiver, GP); standardized data collection form | 2014–2016 | Rx, OTCb | 276 | 49.3 | M 73.9 SD 6.2 Ra 65–92a | M 7.8 SD 3.2a | 91.7 (5 +) |
Radosevic58 |
Croatia EU, HIC |
Cross-sectional | 65 + years & 1 + medication & hospitalised at the internal medicine department | Medical charts | 2007a | Rx | 142 | 52.1a | M 75.0 SD 6.3 Ra 65–97a | M 6.3 SD 2.7a | 73.2 (5 +)a |
Gallagher53 |
Czechia EU, HIC |
Cross-sectional | 65 + years & emergency admission to the geriatric department | Medical charts & patient assessmenta | 2008 | Rx | 150 | 65.3c | Mdn 82 IQR 77–86 | Mdn 6 IQR 4–8 | 52.7 (6 +)c |
Kostkova55 |
Slovakia EU, HIC |
Cross-sectional | 65 + years & hospitalised at the geriatric department & complete medical documentation; excluded who died | Medical charts | 2008–2009 | Rxa | 566 | 62.2 | M 77.4 SD 6.8 | NR | 68.7 admission 87.8 discharge (6 +) |
Wawruch51* Wawruch49 Wawruch50 |
Slovakia EU, HIC |
Cross-sectional | 65 + years & hospitalised at the internal medicine department & complete medical documentation; excluded who died | Medical charts | 2003–2005 | Rx, OTCa | 600 | 58.5 | M 76.6 SD 6.5 | NR | 60.3 admission 62.3 discharge (6 +) |
Community setting | |||||||||||
Fialova59 |
Czechia EU, HIC |
Cross-sectional | 65 + years & home care recipient | Patient assessment & interview (patient, caregiver) & medical charts; standardized data collection formd | 2001–2002 | Rx, OTC | 428 | 79.0 | M 81.6 SD 7.0 Ra 65–98a | M 6.7 SD 2.5a | 68.5 (6 +) |
Kosinska61 |
Poland EU, HIC |
Cross-sectional | 65 + years & 1 + medication | Prescriptions | 2004 | Rx | 5086 (prescriptions) | 64.8 | M 74.5 Ra 65–100 | NR | NR |
Rajska-Neumann63 |
Poland EU, HIC |
Cross-sectional | 65 + years | Questionnaire | 2002–2003a | Rx, OTC | 1000; two cities I: 680 II: 320 | 65.4c |
I: M 72.6 SD 6.5; II: M 72.5 SD 6.0 |
I: M 6.9 SD 3.2; II: M 6.6 SD 3.1 | 50.4 (7 +) |
Rajska-Neumann64 |
Poland EU, HIC |
Cross-sectional | 100 + years | Questionnaire | 1999–2000e | Rx, OTC | 92 | 83.7c | M 101.7 SD 1.2 Ra 100–111 | M 2.5 SD 2.5 | 32.6 (5 +) |
Primejdie48° |
Romania EU, HIC |
Cross-sectional | 65 + years | Prescriptions | 2013 | Rx | 345 | 61.2 | M 74.8 SD 6.2 Ra 65–92 | Mdn 3 | NR |
Kovacevic62 |
Serbia Non-EU, UMIC |
Cross-sectional | 65 + years & 1 + medication; excluded who did not claim prescriptions personally | Interview (patient) & medical charts; standardized data collection form | 2012 | Rx | 509 | 57.4 | M 74.8 SD 6.5 Ra 65–95 | M 5.1 SD 2.2 | 37.0 (6 +) |
Gorup60 |
Slovenia EU, HIC |
Cross-sectional | 65 + years & 1 + medication & capable of giving consent and communicating well & life expectancy > 1 year | Questionnaire (patient) & patient assessment | 2014–2015 | Rx | 503 | 56.7 | M 74.9 SD 6.0 Ra 65–99 | M 5.6 SD 2.9 | 62.2 (5 +) |
LTC setting | |||||||||||
Kalafutova72 |
Czechia EU, HIC |
Cross-sectional | 65 + years & 2 + medications & capable of giving consent and communicating well | Medical charts | 2012 | Rx, OTCb | 58 | 74.1c | M 82.4 SD 8.3 | Rx: M 8.9 OTC: M 1.2 | Rx:82.8 (6 +)c |
Bor71 |
Hungary EU, HIC |
Cross-sectional | Residing 12 + months in the LTC; excluded who diedf | Medical charts | 2010–2015 | Rx, OTCa | 184a | 78.8a | M 82.6 SD 7.2 Ra 65–104a | M 8.5 SD 3.8a | 91.3 (4 +) |
Primejdie48 |
Romania EU, HIC |
Cross-sectional | 65 + years | Medical charts | 2013 | Rx, OTC | 91 | 58.2 | M 80.8 SD 6.8 Ra 65–98 | Mdn 8 | NR |
Stojanovic75 |
Serbia Non-EU, UMIC |
Cross-sectional | 65 + years & 1 + medication | Medical charts | 2018 | Rx | 400 | 69.0c | Mdn 83 IQR 11 Ra 65–99 | Mdn 8 IQR 5 | NR |
Kolar73 |
Slovakia EU, HIC |
Cross-sectional | 65 + years | Medical charts | 2014 | Rx | 70 | 58.6 | M 79.9 SD 5.6 Ra 70–94a | M 8.1 SD 9.8a | 90.0 (5 +)a |
Ster74 |
Slovenia EU, HIC |
Cross-sectional | 65 + years & patient/proxy capable of giving consent & complete medical documentation | Medical charts; standardized data collection form | 2006 | Rx, OTC | 2040 | 78.3 | M 82.0 SD 7.7 | M 5.8 SD 3.0 | 50.6 (6 +) |
Outpatient setting | |||||||||||
Popovic68 |
Croatia EU, HIC |
Cross-sectional | 65 + years & 5 + medications | Claims database | 2010 | Rx | 29,418 | 63.2 | M 77 SD 5.9 Ra 65–103a | M 7.6 SD 1.8a | NA (5 + inclusion criteria) |
Vlahovic-Palcevski70 |
Croatia EU, HIC |
Cross-sectional | 70 + years & 1 + medication | Pharmacy database | 2002 | Rx | 10,426a | NR | NR | M 7.5 | NR |
Vinsova69 |
Czechia EU, HIC |
Cross-sectional | 65 + years & 1 + medication | Claims database | 1997–2001 | Rx | 15,516 | NR | NR | NR | NR |
Grina65 |
Lithuania EU, HIC |
Cross-sectional | 65 + years & 1 + medication | Claims database | 2015 | Rx | 431,625 | 68.1 | M 75.8 SD 0.0 | M 4.7 SD 0.0 | 57.5 (4 +)g |
Jazbar66 |
Slovenia EU, HIC |
Cross-sectional | 65 + years & 1 + medication | Claims database | 2013 | Rx | 345,400 | 60.0 | M 75.4 SD 7.3 Ra 65–108a | M 7.8 SD 4.9a | 72.1 (5 +)a |
Nerat67 |
Slovenia EU, HIC |
Cross-sectional | 65 + years & 1 + medication | Claims database | 2006 | Rx | 65 + : 298,990; 75 + : 136,076 | NR | NR | 65 + : M 7.7 SD 4.9; 75 + : M 8.3 SD 5.0 | NR |
Stuhec52 |
Slovenia EU, HIC |
Uncontrolled before-after | 65 + years & 10 + medications & medication review & complete medical documentation | Medical charts & medication review documentation | 2012–2014 | Rx | 91 | 61.5 | M 77.5 Mdn 78 Ra 65–91 | M 13.8 Mdn 13 | NA (10 + inclusion criteria) |
EU European Union, GP General practitioner, HIC High-income country, IQR Interquartile range, LTC Long-term care, M Mean, Mdn Median, NR Not reported, OTC Over-the-counter medication, Ra Range, Rx Prescription medication, Sd Standard deviation, UMIC Upper-middle-income country.
*Indicates the major publication for the study (the study was described in three reports).
°One report described two studies.
aData were obtained and/or confirmed from study authors.
bDietary supplements were also included.
cCalculated.
dInterRAI Minimum Data Set for Home Care instrument, MDS-HC76.
eData were obtained from publication by Sikora et al.77.
fData for persons aged 65 + years were obtained by correspondence.
gDiscrepancies in publication resolved in correspondence.